Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKRD66 is a protein that contains ankyrin repeat domains, modular protein motifs that typically mediate protein-protein interactions. The ANKRD66 gene is protein-coding and mapped to human chromosome 6. It is listed as associated with Dandy-Walker syndrome in genetic databases, but its specific biological role, molecular mechanisms, and relevance as a therapeutic target have not been characterized. No known drugs or interventions directly target this protein, and it features structurally as an ankyrin repeat-containing protein rather than belonging to a major drug target family such as receptors, enzymes, or ion channels. If you need structured information for database or analytical purposes, the current scientific consensus is that ANKRD66 remains poorly characterized and is not presently considered a therapeutic target. Most available data relates to gene sequence and protein structure classification, not pharmacological or pathophysiological significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 66 (ANKRD66).